NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol |
|
|
| Recruiting | 2 | 600 | US | Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo | U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline | Post Traumatic Stress Disorder | 03/26 | 09/26 | | |
NCT05948579: Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone |
|
|
| Not yet recruiting | 2 | 200 | NA | Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo | U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline | Post Traumatic Stress Disorder | 03/26 | 09/26 | | |
